Why Focus on Treating Diseases Instead of Curing Them?

April 23, 2022

Life Sciences Voice Top Five Newsletter

September 1, 2024

Tvardi Therapeutics Reports Phase 2 Failure for IPF Drug Candidate TTI-101

October 17, 2025

Must Read

Aligos Therapeutics Secures $25 Million by Granting China Rights for HBV Drug Candidate

April 23, 2026

Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion

April 23, 2026

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

April 23, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Aligos Therapeutics Secures $25 Million by Granting China Rights for HBV Drug Candidate

AstraZeneca Reports Phase 3 MIRANDA Trial Success for Tozorakimab in COPD

Travere’s Filspari becomes the first FDA-approved medication for FSGS

IDEAYA and Servier Report Phase 2/3 Trial Success for Darovasertib Combination in Uveal Melanoma

Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

Commercial

Xeris Pharmaceuticals gets stockholder nod on Strongbridge Biopharma acquisition

Editor Picks

Why Focus on Treating Diseases Instead of Curing Them?

Life Sciences Voice Top Five Newsletter

Tvardi Therapeutics Reports Phase 2 Failure for IPF Drug Candidate TTI-101

Must Read

Aligos Therapeutics Secures $25 Million by Granting China Rights for HBV Drug Candidate

Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

Hot Topics

About Us

Follow Us